Li Xinwei, Xiao Wen, Yang Hongmei, Zhang Xiaoping
Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Institute of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Oncol. 2024 Sep 4;14:1458616. doi: 10.3389/fonc.2024.1458616. eCollection 2024.
Renal cell carcinoma is a urological malignancy with a high metastatic rate, while targeted therapy for renal cell carcinoma still has much room for improvement. Some cutting-edge researches have focused on exosome in cancer treatment and there are some breakthroughs in breast cancer, lung cancer, and pancreatic cancer. Up to now, exosome in renal cell carcinoma progression and implications for targeted therapy has been under research by scientists. In this review, we have summarized the structure, formation, uptake, functions, and detection of exosomes, classified the mechanisms of exosomes that cause renal cell carcinoma progression, and listed the promising utilization of exosomes in targeted therapy for renal cell carcinoma. In all, based on the mechanisms of exosomes causing renal cell carcinoma progression and borrowing the successful experience from renal cell carcinoma models and other cancers, exosomes will possibly be a promising target for therapy in renal cell carcinoma in the foreseeable future.
肾细胞癌是一种转移率很高的泌尿系统恶性肿瘤,而肾细胞癌的靶向治疗仍有很大的改进空间。一些前沿研究聚焦于外泌体在癌症治疗中的应用,并且在乳腺癌、肺癌和胰腺癌方面取得了一些突破。到目前为止,科学家们一直在研究外泌体在肾细胞癌进展中的作用及其对靶向治疗的意义。在这篇综述中,我们总结了外泌体的结构、形成、摄取、功能和检测方法,对外泌体导致肾细胞癌进展的机制进行了分类,并列举了外泌体在肾细胞癌靶向治疗中的潜在应用。总之,基于外泌体导致肾细胞癌进展的机制,并借鉴肾细胞癌模型和其他癌症的成功经验,在可预见的未来,外泌体可能会成为肾细胞癌治疗的一个有前景的靶点。